Ken Sagou

5PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 17, 2025
Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.

Hyeongki Park, Naotoshi Nakamura, Sho Miyamoto

|Feb 18, 2021
Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.

Ken Sagou, Makoto Ito, Yuma Kawamura

|Sep 03, 2020
Intrapatient variability in concentration/dose ratio of tacrolimus predicts transplant-associated thrombotic microangiopathy.

Ken Sagou, Nobuaki Fukushima, Shun Ukai

|Aug 05, 2020
Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy.

Ken Sagou, Nobuaki Fukushima, Shun Ukai

|Jan 04, 2019
Decline of forced expiratory volume in 1 s after allogeneic hematopoietic cell transplantation is a good indicator for pulmonary damage and is associated with busulfan use.

Ken Sagou, Shun Ukai, Yoshitaka Adachi

Pageof 1

Frequent Collaborators

1 joint publications

Hyeongki Park

1 joint publications

Naotoshi Nakamura

1 joint publications

Sho Miyamoto

1 joint publications

Yoshitaka Sato